Join us in welcoming SetPoint Medical to the Norwest portfolio! The company is poised to transform the lives of millions with chronic inflammatory diseases. Its device-based therapy has the potential to treat autoimmune diseases without compromising patients’ immune systems.

🤝Read our investment team’s blog to learn more about how SetPoint Medical is changing the game for #autoimmune disease treatment: nvp.com/blog/setpoint-…

Data accumulates targeting the Vagus Nerve inflammatory reflex is giving hope for future options beyond biologics and JAK inhibitors. Is a tipping point approaching ? I really hope so. ⁦Peder S Olofsson⁩ ⁦American College of Rheumatology⁩ ⁦SetPoint Medical⁩ the-rheumatologist.org/article/resear…

We're working to prove the value of neuroimmune modulation in #rheumatology, aiming to bring new options for patients. "This is the brand-new field of neuromodulation for the treatment of autoimmune disease,” explains our CMO. Check out the latest buzz: the-rheumatologist.org/article/resear…

SetPoint Medical’s co-founder Prof. Kevin J. Tracey, MD spoke with Katie Couric about the innovative field of neuroimmune modulation and our ongoing RESET-RA trial investigating this novel treatment option for RA patients. Check it out: katiecouric.com/health/vagus-n…

🎉 Big news incoming: SetPoint’s novel neuroimmune modulation platform received Breakthrough Device Designation from the FDA for multiple sclerosis (MS) treatment! Learn more here: #MSAwarenessWeek #TheSetPointAdvantage setpointmedical.com/setpoint-medic…

We're happy to share that, following the recent Breakthrough Device Designation, Setpoint's neuroimmune modulation platform for the treatment of MS has now been accepted into the FDA's TAP Pilot! #TheSetPointAdvantage Learn more in our press release: setpointmedical.com/setpoint-medic…

We're thrilled to announce positive topline results from our RESET-RA clinical study for rheumatoid arthritis (#RA)! The Setpoint System is limited by United States law to investigational use only. Read the full announcement: setpointmedical.com/setpoint-medic… #TheSetPointAdvantage

Congrats to SetPoint Medical for proving the inflammatory reflex benefits patients with RA ! Now onto other autoimmune conditions.... "The study met its primary endpoint with a statistically significant greater proportion of study participants achieving an ACR20 response in the

We're excited to announce late-breaking data from the RESET-RA study at American College of Rheumatology #ACR24 supporting the SetPoint System's potential as a first-of-its-kind neuroimmune modulation treatment for rheumatoid arthritis (#RA). Learn more in our press release: setpointmedical.com/setpoint-medic…

Nice story by NPR about how neuroimmune modulation is unlocking new possibilities for treating autoimmune diseases like #RA. npr.org/sections/shots… #TheSetPointAdvantage The SetPoint System is limited by U.S. law to investigational use only.

We were honored to have our national surgical PI Mark Richardson MD PhD present RESET-RA results during the Plenary Session at #AANS25. Data presented highlight SetPoint System’s potential as a first-of-its-kind neuroimmune modulation treatment for RA. #TheSetPointAdvantage

We're so pleased to see this coverage of the FDA approval of the #SetPointSystem in the The New York Times! Read the full story to learn more about the life-changing power of neuroimmune modulation: nytimes.com/2025/07/31/hea… Safety info in bio. #Rheumatology #RheumTwitter #MedTwitter

Controlling the immune system and inflammation through stimulating the vagus nerve. FDA approval of an implant for refractory rheumatoid arthritis that is also being studied for various autoimmune diseases. Front page The New York Times great work by Prof. Kevin J. Tracey, MD SetPoint Medical

Big ambition takes big investment and audacious leadership -- that's why we're excited to announce today that we've secured $140 million in private financing, and welcomed key new executives to our leadership team and board of directors. Read more: setpointmedical.com/setpoint-medic…